- Home
- BANC vs OCUL Comparison
BANC vs OCUL Comparison
Compare BANC & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANC
- OCUL
- Stock Information
- Founded
- BANC 1941
- OCUL 2006
- Country
- BANC United States
- OCUL United States
- Employees
- BANC N/A
- OCUL N/A
- Industry
- BANC Major Banks
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- BANC Finance
- OCUL Health Care
- Exchange
- BANC Nasdaq
- OCUL Nasdaq
- Market Cap
- BANC 2.6B
- OCUL 2.3B
- IPO Year
- BANC N/A
- OCUL 2014
- Fundamental
- Price
- BANC $17.06
- OCUL $12.71
- Analyst Decision
- BANC Buy
- OCUL Strong Buy
- Analyst Count
- BANC 11
- OCUL 7
- Target Price
- BANC $17.18
- OCUL $17.83
- AVG Volume (30 Days)
- BANC 2.1M
- OCUL 2.2M
- Earning Date
- BANC 10-21-2025
- OCUL 11-13-2025
- Dividend Yield
- BANC 2.35%
- OCUL N/A
- EPS Growth
- BANC N/A
- OCUL N/A
- EPS
- BANC 0.65
- OCUL N/A
- Revenue
- BANC $949,659,000.00
- OCUL $56,664,000.00
- Revenue This Year
- BANC $7.25
- OCUL N/A
- Revenue Next Year
- BANC $10.78
- OCUL $18.87
- P/E Ratio
- BANC $26.28
- OCUL N/A
- Revenue Growth
- BANC 150.32
- OCUL N/A
- 52 Week Low
- BANC $11.52
- OCUL $5.79
- 52 Week High
- BANC $18.08
- OCUL $13.85
- Technical
- Relative Strength Index (RSI)
- BANC 66.73
- OCUL 53.64
- Support Level
- BANC $16.13
- OCUL $12.27
- Resistance Level
- BANC $17.02
- OCUL $13.07
- Average True Range (ATR)
- BANC 0.35
- OCUL 0.64
- MACD
- BANC -0.07
- OCUL -0.08
- Stochastic Oscillator
- BANC 84.86
- OCUL 37.70
About BANC Banc of California Inc.
Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.